• Citer

Case study analysis on behalf of IMI JU Executive Office under a service contract procedure: SUMMIT - IMIDIA – Open PHACTS - NEWMEDS – eTOX – U-BIOPRED: Innovative Medicines Initiative Joint Undertaking (IMI). Summary in the Annual Activity Report 2013

par Stevens, Hilde ;Huys, Isabelle
Organisme financeur Innovative Medicines Initiative Joint Undertaking (IMI)
Publication Publié, 2014

Rapport

• Détails

Titre:	Case study analysis on behalf of IMI JU Executive Office under a service contract procedure: SUMMIT - IMIDIA – Open PHACTS - NEWMEDS – eTOX – U-BIOPRED: Innovative Medicines Initiative Joint Undertaking (IMI). Summary in the Annual Activity Report 2013
Auteur:	Stevens, Hilde; Huys, Isabelle
Organisme financeur:	Innovative Medicines Initiative Joint Undertaking (IMI)
Statut de publication:	Publié, 2014
series:	Annual Activity Report
Sujet CREF:	Sciences biomédicales en général
	Droits intellectuels
	Disciplines biomédicales diverses
Volumes/pages:	118 p.
Mots-clés:	Innovative Medicines Initiative
	IMI
	Public-Private Partnership
	Intellectual Property
	IP
	Consortium
Langue:	Anglais
Identificateurs:	http://www.europarl.europa.eu/document/activities/cont/201408/20140818ATT87695/20140818ATT87695EN.pdf: IMI.